Keeping you up to date with the latest clinical trial information
Alzheimer's Disease
Interleukin-1 mediates Alzheimer and Lewy body pathologies
Parkinson's disease (PD), once thought of as a purely motor disorder, is linked to Alzheimer's disease (AD) in several ways.
Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients
Alzheimer disease (AD), the most common cause of dementia in the elderly, is clinically characterized by progressive cognitive impairment associated with severe neuropsychiatric disturbances.
Test Your Knowledge: Ten Questions about Dementia
This quiz is related to the Best Practice article in the January issue of PLoS Medicine
(DOI: 10.1371/journal.pmed.0020007).
Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
The Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE) prevention trial is an important addition to the Selenium and Vitamin E Cancer Prevention Trial (SELECT). As a prevention trial, PREADVISE is trying to find out if taking selenium and/or Vitamin E supplements can help to prevent memory loss and dementia such as Alzheimer's disease.
Selected Reading
Huperzine A in Alzheimer's Disease
The present study will evaluate the safety and efficacy of the Chinese herb huperzine A in the treatment of Alzheimer's disease (AD) in a randomized controlled trial of its effect on cognitive function.
Selected Reading
Depression in Alzheimer's Disease
The purpose of this study is to learn whether treating individuals with Alzheimer's disease and depression with the anti-depressant medication sertraline (Zoloft) is helpful to people with Alzheimer's disease and to their families and caregivers.
Selected Reading
| Guidelines Watch |
 |
|
A round up of the latest Clinical Guidelines from the National Guideline Clearinghouse (NGC)
Dementias
Management of patients with dementia. A national clinical guideline
Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.]. 1998 Feb (revised 2006 Feb). 53 pages. NGC:004855
Dementia
American Medical Directors Association - Professional Association. 1998 (revised 2005). 28 pages. NGC:004446
|
Aricept ODT is a new disintegrating tablet dosage form designed to make administration easier for patients with Alzheimer’s disease. Studies have shown these patients may develop difficulty with swallowing. Aricept ODT will be available in the U.S. in the second quarter of 2005
